Vontobel Holding Ltd. Ultragenyx Pharmaceutical Inc. Transaction History

Vontobel Holding Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 03, 2024	BUY	$36.99 - $48.71 $1.05 Million - $1.38 Million	28,424 New	28,424 $1.14 Million
Q1 2023 Apr 12, 2023	SELL	$36.99 - $48.71 $166,233 - $218,902	-4,494 Reduced 13.65%	28,424 $1.14 Million
Q4 2022 Feb 14, 2023	BUY	$33.72 - $46.33 $1.11 Million - $1.53 Million	32,918 New	32,918 $1.53 Million
Q3 2021 Oct 29, 2021	SELL	$77.92 - $102.4 $24,856 - $32,665	-319 Reduced 2.33%	13,382 $1.21 Million
Q2 2021 Aug 06, 2021	BUY	$92.19 - $115.71 $1.26 Million - $1.59 Million	13,701 New	13,701 $1.31 Million

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.